| |
| |
|
| Insider
Information: |
Carter Eric G |
| Relationship: |
Director |
| City: |
Bristol |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
48,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$466,560 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,000 |
|
|
| Total
Value |
$466,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
King Pharmaceuticals Inc |
KG |
Chief Science Officer |
2011-01-31 |
0 |
2007-03-21 |
0 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
Director |
2017-09-07 |
48,000 |
2017-09-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2017-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
48,000 |
48,000 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2011-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,740) |
0 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2011-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(135,427) |
38,740 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2011-01-07 |
4/A |
A |
$0.00 |
$0 |
D/D |
16,260 |
174,167 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2011-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
16,260 |
136,227 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,940 |
174,167 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-11-29 |
4 |
D |
$14.15 |
$572,028 |
D/D |
(40,426) |
119,967 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-03-22 |
4 |
D |
$12.25 |
$21,707 |
D/D |
(1,772) |
164,514 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,970 |
166,286 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-03-10 |
4 |
D |
$12.22 |
$50,359 |
D/D |
(4,121) |
160,393 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2010-01-25 |
4 |
D |
$12.35 |
$55,859 |
D/D |
(4,523) |
154,316 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2009-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,698 |
158,839 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2009-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,930 |
146,141 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2009-03-10 |
4 |
D |
$6.31 |
$3,370 |
D/D |
(534) |
130,211 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2009-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,645 |
130,745 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,840 |
129,100 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2007-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
118,260 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2007-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,460 |
18,260 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Science Officer |
• – – |
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
